相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Key strategic factors for stakeholders in the current global biosimilar market
Daniel Casey
DRUG DISCOVERY TODAY (2016)
Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD
Polina Putrik et al.
RHEUMATOLOGY (2016)
Patient attitudes and understanding about biosimilars: an international cross-sectional survey
Ira Jacobs et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
Evelien Moorkens et al.
FRONTIERS IN PHARMACOLOGY (2016)
Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients
Jorgen Jahnsen
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names
Jingdong Chao et al.
ADVANCES IN THERAPY (2015)
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Inequities in access to biologic and synthetic DMARDs across 46 European countries
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
Ingrid Nota et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization
Silvio Danese et al.
JOURNAL OF CROHNS & COLITIS (2014)
Biosimilars in Oncology: From Development to Clinical Practice
Katherine H. Rak Tkaczuk et al.
SEMINARS IN ONCOLOGY (2014)
Biosimilars naming, label transparency and authority of choice - survey findings among European physicians
Richard O. Dolinar et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2014)
Approval of the first biosimilar antibodies in Europe A major landmark for the biopharmaceutical industry
Alain Beck et al.
MABS (2013)
Biosimilars in oncology: current and future perspectives
Matti Aapro
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2013)
Biosimilar agents in oncology/haematology: from approval to practice
Dietger Niederwieser et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand
P. Anderson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
分享论文
